Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain.
Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatological actives, such as lipophilics and hydrophilics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 2, 2011 | Seed | €500K | 1 | Fundación Caja Navarra | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Fundación Caja Navarra | Yes | Seed |